AL
SABA

Aspiriant LLC’s Saba Capital Income & Opportunities Fund II SABA Stock Holding History

Aspiriant LLC’s Portfolio SABA Stock Details SABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-75,499
Closed -$18K – 71
2013
Q3 		$18K Buy
+75,499
New +$1.25M ﹤0.01% 50

Other funds holding SABA

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
B
Baird Milwaukee, Wisconsin $9.78B AUM 11.39% 1-Year Est. Return
EAM
Evanson Asset Management Carmel, California $1.86B AUM 25.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WCM
Windsor Capital Management Phoenix, Arizona $385M AUM 17.95% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

Aspiriant LLC's SABA Position: Q4 2013 in Review

Aspiriant LLC sold out of Saba Capital Income & Opportunities Fund II (SABA) in Q4 2013, closing a stake of 75,499 shares — an estimated $18K sold.

Aspiriant LLC first reported a position in SABA in Q3 2013 and held it in 1 quarter. The position peaked at $18K in Q3 2013. 118 funds tracked by Wall St. Rank hold SABA as of Q4 2013.

  • Aspiriant LLC reported no remaining Saba Capital Income & Opportunities Fund II position as of Q4 2013 after selling out during the quarter.
  • Aspiriant LLC sold 75,499 Saba Capital Income & Opportunities Fund II shares in Q4 2013, an estimated $18K.
  • Aspiriant LLC first reported a position in Saba Capital Income & Opportunities Fund II in Q3 2013 and held it in 1 quarter.
  • Aspiriant LLC's Saba Capital Income & Opportunities Fund II position peaked at $18K in Q3 2013.
  • 118 funds tracked by Wall St. Rank held Saba Capital Income & Opportunities Fund II as of Q4 2013.

Based on Aspiriant LLC's 13F filing for Q4 2013, filed 11 Feb 2014.